Comprehensive Management Plan for 13-Day-Old Late-Preterm Infant with Suspected Sepsis
Antibiotic Therapy
Ampicillin plus gentamicin is the recommended empiric antibiotic regimen for this infant, providing coverage against Group B Streptococcus and gram-negative organisms including E. coli. 1, 2, 3
Dosing Regimen (assuming weight ~3 kg)
- Ampicillin: 50 mg/kg IV every 8 hours (for infants 8-28 days of age without meningitis) 1
- Gentamicin: 4-5 mg/kg IV every 24 hours (extended-interval dosing for infants >7 days and >34 weeks gestational age) 2
Key consideration: At 13 days of age, this infant falls into the 8-28 day age category where ampicillin and gentamicin remain first-line, though broader-spectrum therapy with ceftazidime may be considered if there is concern for ampicillin resistance. 1 However, avoid routine use of cefotaxime as it is associated with increased mortality compared to gentamicin (adjusted OR 1.5,95% CI 1.4-1.7) and promotes emergence of resistant organisms. 4, 5
Duration of Therapy
- If blood cultures are negative at 48 hours and infant is clinically well: Discontinue antibiotics 6
- If cultures are positive: Continue therapy for 7-10 days for bacteremia without focus, 14 days for meningitis 1
- Monitor: Obtain gentamicin trough level before 3rd dose to ensure <2 mcg/mL; monitor renal function and hearing 2
Septic Work-Up Components
Laboratory Evaluation Completed
Full diagnostic evaluation should include: 1
- Blood culture (obtained before antibiotics) 1, 2
- Complete blood count with differential and platelet count (ideally at 6-12 hours of life for initial evaluation, but at presentation for late evaluation) 1, 6
- Lumbar puncture with cerebrospinal fluid analysis if infant is stable enough to tolerate procedure and sepsis is suspected 1
- Chest radiograph if respiratory abnormalities are present 1
- Urine culture (for late-onset sepsis evaluation in infants >7 days) 1
Expected CBC Findings to Monitor
- Abnormal findings suggesting sepsis: WBC <5,000 or >25,000/mm³, absolute neutrophil count <1,500/mm³, I:T ratio >0.2, thrombocytopenia <100,000/mm³ 1, 2
- Thrombocytopenia does not contraindicate ampicillin-gentamicin use 2
Supportive Care
Monitoring Requirements
- Vital signs every 4 hours: Temperature, heart rate, respiratory rate, blood pressure 1
- Continuous cardiorespiratory monitoring for apnea, bradycardia, desaturation 1
- Daily weights and strict intake/output monitoring 1
- Serial CBCs: Repeat at 24-48 hours if initial values abnormal 1
- Blood glucose monitoring every 6-12 hours initially 1
Nutritional Support
- Continue feeding if tolerated (oral or gavage) unless signs of NEC or hemodynamic instability 1
- Target intake: 150-160 mL/kg/day by 13 days of age for term/late-preterm infants 1
- Monitor for feeding intolerance: Abdominal distension, emesis, bloody stools 1
Newborn Screening Requirements
Metabolic Screening
For a 13-day-old infant, verify completion of: 1
- Initial newborn screen (typically done 24-48 hours after birth)
- Repeat newborn screen (recommended at 1-2 weeks for late-preterm infants born at 37 5/7 weeks due to risk of false negatives from early discharge) 1
- Conditions screened: PKU, hypothyroidism, galactosemia, sickle cell disease, cystic fibrosis, and 25+ other metabolic disorders depending on state 1
Hearing Screening
- Automated auditory brainstem response (AABR) or otoacoustic emissions (OAE) should be completed before discharge 1
- Gentamicin exposure requires follow-up hearing evaluation at 6 months due to ototoxicity risk 2
Critical Congenital Heart Disease Screening
- Pulse oximetry screening should have been completed after 24 hours of age but before discharge from birth hospitalization 1
- If not done: Perform now, though sensitivity decreases with age 1
Immunization Status
Hepatitis B Vaccine
For a 13-day-old infant at 37 5/7 weeks gestation: 1
- If birth weight ≥2 kg: First dose should have been given before initial hospital discharge 1
- If not yet given: Administer first dose now (can be given during sepsis evaluation if infant is stable) 1
- Schedule: Second dose at 1-2 months, third dose at 6-18 months 1
Other Vaccines
- No other vaccines are due until 2-month visit 1
- Delay routine 2-month vaccines if infant remains hospitalized or acutely ill 1
Discharge Readiness Criteria
Clinical Stability Requirements
Infant must meet ALL of the following before discharge: 1
- Afebrile for ≥24 hours (temperature 36.5-37.5°C) without antipyretics 1
- Stable vital signs for ≥24 hours (HR 100-160, RR <60, no apnea/bradycardia) 1
- Feeding well with adequate intake (>100 mL/kg/day) and appropriate weight gain or stable weight 1
- Blood cultures negative for ≥48 hours (ideally 72 hours for late-onset sepsis) 1
- Clinical improvement: Resolution of lethargy, improved perfusion, normal activity level 1
Minimum Observation Period
- At least 48 hours of observation after initiating antibiotics, even if cultures are negative 1
- For this 13-day-old infant: If cultures remain negative and clinical course is reassuring, antibiotics can be discontinued at 48 hours and discharge considered at that time 1, 6
Laboratory Requirements Before Discharge
- Repeat CBC showing improvement or normalization of abnormal values 1
- Negative blood cultures at 48-72 hours 1
- Bilirubin level if jaundice present (late-preterm infants at higher risk) 1
- Newborn screening results reviewed and follow-up arranged for any abnormal results 1
Social and Follow-Up Requirements
Before discharge, ensure: 1
- Parent education on signs of sepsis recurrence: fever, lethargy, poor feeding, irritability, respiratory distress 1
- Car seat safety test completed (required for infants <37 weeks at birth) 1
- Follow-up appointment scheduled within 24-48 hours of discharge 1
- Primary care provider identified and notified of hospitalization 1
- Access to medical care readily available and parent able to comply with home observation instructions 1
Special Considerations for Late-Preterm Infant (37 5/7 weeks)
Increased Risk Factors
- Late-preterm infants have 3-fold higher risk of early-onset sepsis compared to term infants 1
- Higher risk of feeding difficulties, hypoglycemia, hyperbilirubinemia, and temperature instability 1
- Immature immune system increases susceptibility to infection 1
Common Pitfalls to Avoid
- Do NOT use cefotaxime routinely in place of gentamicin due to increased mortality risk and emergence of resistant organisms 4, 5
- Do NOT delay antibiotic initiation while awaiting lumbar puncture if infant is unstable 1, 2
- Do NOT discharge before 48 hours of observation even if initial cultures are negative 1
- Do NOT assume adequate intrapartum prophylaxis eliminates sepsis risk; this infant is 13 days old and at risk for late-onset sepsis from different pathogens 1
- Do NOT forget gentamicin level monitoring to prevent nephrotoxicity and ototoxicity 2
Maternal History Considerations
Review maternal records for: 1, 3, 6
- Group B Streptococcus status and adequacy of intrapartum prophylaxis (≥4 hours of penicillin, ampicillin, or cefazolin before delivery) 1
- Chorioamnionitis (maternal fever, fetal tachycardia, uterine tenderness) 1, 3, 6
- Duration of membrane rupture (≥18 hours increases risk) 1
- Maternal antibiotics received during labor 1